SPRC

distress 6/10 · elevated risk

$5.01+4%today-93% from 52w high

scisparc.com3 employeesFounded 2004Tel Aviv-Yafo, IsraelBiotechnology

Revenue

pre-revenue

Liquidity

$6M

Runway

1.4 yrs

Shares 1y

Price & events

-44.9% over 6M

CatalystRating changeDilutionFinancingdashed = today

+3.5%

-6.5%

-27.6%

-23.9%

-44.9%

-93.0%

-95.1%

—

-100.0%

All

Overview

Market Cap: $1.83M
Volume: 5.72K
52 Week Range: $3.06 – $73.71
Total Shares: 365.44K
Float Shares: 553.39K
Short %: 4.55%
% Held by Insiders: 0.00%
% Held by Institutions: 0.55%
RVOL: 0.15x
Beta: 2.48

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 365,444 · 3 offerings/1y · 0 PIPEs

2026-02-17F-3shelf_registration
2026-02-12EFFECTshelf_effective
2026-02-03F-3shelf_registration
2026-01-14424B5offering
2026-01-12EFFECTshelf_effective
2025-11-28424B5offering
2025-11-04424B3offering

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified